LaborMed Pharma inaugurates new factory

Newsroom 17/08/2007 | 17:05

The factory, located in Sector 3 of Bucharest, is a greenfield investment through reinvesting profits and attracting capital and was designed for closed-circuit drug production with the entire fabrication process being monitored by computer.

The factory took two years to design and build, and the work involved a team of company specialists and foreign experts. It is equipped with modern technology imported mainly from Austria, Germany and Italy. Following a six-month equipment trial by foreign experts, the factory was granted a GMP certificate and in May it is expected to release the first stock of medicines that will be sold in pharmacies.

The factory will have a production of 1.5 billion drug doses per year which will cover the full range of 80 generic drugs in the company's portfolio, to which seven other products will be added once they are launched this year.
LaborMed Pharma operates on the Romanian market mainly in the sector of cardiovascular products, but also in five other therapeutic segments.

With a staff of 380 people and 17 years of experience, the company holds a market share of approximately 2 percent and is currently ranked 17th among local pharmaceutical corporations. LaborMed Pharma ended last year with EUR 26 million in turnover, which marked a 32.4 percent increase on 2005.

Otilia Haraga

BR Magazine | Latest Issue

Download PDF or read online: October 2022 Issue | Business Review Magazine

The October 2022 issue of Business Review Magazine is now available in digital format, featuring the main cover story titled “Globalworth Successfully Addressing Market Challenges From a Position
Newsroom | 26/10/2022 | 17:53

    You will receive a download link for the latest issue of Business Review Magazine in PDF format, based on the completion of the form below.

    I agree with the Privacy policy of
    I agree with the storage and handling of my data by
    Advertisement Advertisement
    Close ×

    We use cookies for keeping our website reliable and secure, personalising content and ads, providing social media features and to analyse how our website is used.

    Accept & continue